Clin2
NCT07751159Possibly a fitRecruiting

Comparing radiation therapy methods for prostate cancer

Prostate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This study compares two types of radiation therapy for prostate cancer that hasn't spread. It aims to find which approach is more effective and has fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
126 people
Ages
Any age
Study type
Interventional

Who can take part

  • You have prostate cancer that has not spread to other parts of the body.
  • Your cancer is classified as unfavorable intermediate, high, or very high risk according to NCCN guidelines.
  • Your radiation oncologist has determined you are suitable for both HDR brachytherapy boost and SBRT.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04861415Recruiting
Testing a shorter radiation plan versus standard prostate radiation

This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.

Toronto, Ontario
NCT07426055Recruiting· Phase 2/Phase 3
Prostate cancer radiation boost comparison study

This trial compares two types of radiation treatments for prostate cancer that has not spread to lymph nodes or other parts of the body. It tests whether adding a higher dose of radiation to the main tumor helps control the cancer better than standard radiation alone.

Zamość, Lublin Voivodeship
NCT03424850Recruiting· Phase 1/Phase 2
Tested different radiation doses for early prostate cancer

This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.

St Louis, Missouri
NCT06200974Recruiting
Genetic study of HDR brachytherapy for low-risk prostate cancer

This study looks at a type of radiation therapy called HDR brachytherapy for men with low-risk or slightly higher risk prostate cancer. It aims to understand how your genes affect treatment outcomes.

Kelowna, British Columbia
NCT04100174Recruiting· Phase 2
HDR radiation boost for prostate cancer during standard treatment

This study tests adding a targeted “boost” of HDR (high-dose-rate) internal radiation to the prostate along with standard external beam radiation. It may help improve cancer control while keeping the treatment focused on the area seen on scans and biopsy.

Montreal, Quebec
NCT05754580Recruiting
Boost radiation for intermediate or higher-risk prostate cancer

This study tests a stronger, focused radiation plan for intermediate to higher-risk prostate cancer. It combines a high-dose internal radiation “boost” with external radiation to try to improve cancer control while keeping side effects manageable.

Omaha, Nebraska

Hear when a new Prostate Cancer Patients trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.